Proof-of-concept Randomized, Double-blind, Phase IIa Study to Show Feasibility, Validate Assays and Approaches, and Explore Dosing and Safety of Belimumab in Pulmonary Emphysema Patients
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2018
At a glance
- Drugs Belimumab (Primary)
- Indications Emphysema
- Focus Pharmacodynamics; Proof of concept
- Acronyms BOTEGA
- 09 Apr 2018 Planned End Date changed from 1 Dec 2019 to 1 May 2020.
- 09 Apr 2018 Planned primary completion date changed from 1 Dec 2019 to 1 May 2020.
- 09 Apr 2018 Planned initiation date changed from 1 Mar 2018 to 1 May 2018.